Indaptus Therapeutics Inc

NASDAQ:INDP   4:00:00 PM EDT
2.24
-0.25 (-10.04%)
5:28:54 PM EDT: $2.47 +0.23 (+10.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Indaptus Therapeutics Inc Stock, NASDAQ:INDP

3 Columbus Circle, 15th floor, New York, New York 10019
Israel
Phone: +1.646.427.2727
Number of Employees: 7

Description

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.